EMA Puts Temporary Restrictions on Tofacitinib Due to PE Risk
The EMA’s safety committee advises physicians not to prescribe the 10-mg twice-daily dose of tofacitinib to patients who are at high risk for pulmonary embolism, pending results of an ongoing safety review. News Alerts …read more